Market Tracker

09/29 9:38am ET
33.30
BATS BZX Real-Time Price
As of 9:38am ET
 -0.52 / -1.54%
Today’s Change
26.97
Today|||52-Week Range
35.04
-1.91%
Year-to-Date
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
Read Scraps Pfizer Break-up As Megadeals Escape Its Grasp
Sep 26 / TheStreet.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Here's How to Find the Best Dividend Stocks
Sep 23 / MotleyFool.com - Paid Partner Content
AstraZeneca Diabetes Drug Combination Positive in Phase III
Sep 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content
10 Stocks Dodge & Cox Keep Buying
Sep 22 / GuruFocus News - Paid Partner Content
6 Flu Season Facts You Probably Don't Know
Sep 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close33.82
Today’s open33.46
Day’s range33.30 - 34.08
Volume20,117
Average volume (3 months)5,715,662
Market cap$85.6B
Dividend yield4.20%
Data as of 9:38am ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-1.11%
Earnings growth (next 5 years)+0.10%
Revenue growth (last year)-5.11%
P/E ratio38.7
Price/Sales3.48
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-1.16-2.65%
LLYEli Lilly and Co-0.51-0.63%
CELGCelgene-0.07-0.07%
BMYBristol-Myers Squibb-0.09-0.16%
Data as of 9:38am ET, 09/29/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)$0.57
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts